Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • VIEKIRA PAK associated drug-in...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature

VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature

Bibliographic Details
Main Authors: Yu Jun Wong, Si Yuan Chew, John Chen Hsiang, Prem Harichander Thurairajah, Rahul Kumar, Eng Kiong Teo, Roshni Sadashiv Gokhale, Imran Bin Mohamed Noor, Jessica Tan
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2019-03-01
Series:Clinical and Molecular Hepatology
Online Access:http://e-cmh.org/upload/pdf/cmh-2018-0017.pdf
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://e-cmh.org/upload/pdf/cmh-2018-0017.pdf

Similar Items

  • Viekira Pak Induced Fatal Lactic Acidosis: A Case Report of an Unusual Side Effect
    by: Molham Abdulsamad, et al.
    Published: (2016-01-01)
  • Ombitasvir/paritaprevir/ritonavir+dasabuvir and ribavirin associated drug-induced liver injury and syndrome of inappropriate secretion of anti-diuretic hormone: A case report
    by: Rahul Kumar, et al.
    Published: (2019-09-01)
  • Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction
    by: Shih Yea Sylvia Wu, et al.
    Published: (2017-01-01)
  • The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
    by: Yu Jun Wong, et al.
    Published: (2021-07-01)
  • Economic evaluation of direct‐acting antivirals for the treatment of genotype 3 hepatitis C infection in Singapore
    by: Yu‐Jun Wong, et al.
    Published: (2019-06-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs